Norway Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Norway Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report provides granular analysis of the Norway diagnostic testing market, including volume and sales forecasts by test for the following market segments:

– Blood Banking
– Cancer
– Chemistry
– Coagulation
– Drugs of Abuse
– Endocrine
– Hematology and Flow Cytometry
– Immunoprotein
– Infectious Diseases
– Molecular Diagnostics
– TDM

Table of Contents

Market Overview

Blood Banking Market

Table 1: Blood Bank Test Volume and Reagent Sales Forecast by Test Category

Table 2: Blood Typing and Grouping Volume Forecast by Test

Table 3: Infectious Disease Screening Volume Forecast by Test

Table 4: Blood Typing and Grouping Reagent Market Forecast by Test

Table 5: Infectious Disease Screening Reagent Market Forecast by Test

Cancer Diagnostics Market

Table 6: Cancer Diagnostic Volume Forecast by Test

Table 7: Cancer Diagnostics Sales Forecast by Test

Clinical Chemistry and Immunodiagnostics Market

Table 8: Routine Chemistry Volume Forecast by Test

Table 9: Endocrine Function Volume Forecast by Test

Table 10: Tumor Markers and Special Chemistry Volume Forecast by Test

Table 11: Tumor Markers and Special Chemistry Volume Forecast by Test

Table 12: Immunoprotein Volume Forecast by Test

Table 13: TDM Volume Forecast by Test

Table 14: Drugs of Abuse Volume Forecast by Test

Table 15: Clinical Chemistry and Immunoassay Calibrator and Control Market
Forecast by Test Category

Table 16: Routine Chemistry Reagent Market Forecast by Test

Table 17: Endocrine Function Reagent Market Forecast by Test

Table 18: Tumor Markers and Special Chemistry Reagent Market Forecast by Test

Table 19: Immunoprotein Reagent Market Forecast by Test

Table 20: TDM Reagent Market Forecast by Test

Table 21: Drugs of Abuse Reagent Market Forecast by Test

Table 22: Clinical Chemistry and Immunoassay Instrument Market Forecast by
Analyzer Type

Coagulation Testing Market

Table 23: Coagulation Test Volume Forecast by Procedure

Table 24: Coagulation Diagnostics Market Forecast by Product Category

Hematology and Flow Cytometry Markets

Table 25: Hematology and Flow Cytometry Specimen Volume Forecast

Table 26: Hematology and Flow Cytometry Volume Forecast

Table 27: Hematology and Flow Cytometry Market Forecast

Table 28: Routine Hematology Volume Forecast by Test

Table 29: Flow Cytometry and Special Hematology Volume Forecast by Test

Infectious Disease Testing Market

Table 30: Infectious Disease Volume Forecast by Test

Table 31: Infectious Disease Diagnostics Market Forecast by Test

Molecular Diagnostics Market

Table 32: Molecular Diagnostic Test Volume and Sales Forecasts by Application

Table 33: Molecular Diagnostic Test Volume Forecast by Application

Table 34: Infectious Disease Volume Forecast by Test

Table 35: Molecular Diagnostics Market Forecast by Application

Table 36: Infectious Disease Diagnostics Market Forecast by Test

Contains 40 pages and 36 tables.

Read more and order at Norway Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Austria Nucleic Acid Testing (NAT) Market 2021: Supplier Strategies, Country Volume and Sales Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2017 Austria Nucleic Acid Testing (NAT) Market 2021: Supplier Strategies, Country Volume and Sales Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights:

  • Five-year test volume and sales forecasts
  • Feature comparison of major analyzers
  • Profiles of market players and start-up firms developing innovative technologies and products
  • Specific product and business opportunities for instrument and consumable suppliers.

Rationale:

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis:

  • Five-year test volume and sales forecasts for major applications, including:
  • Infectious Diseases
  • Forensic Testing
  • Cancer
  • Paternity Testing/HLA Typing
  • Genetic Diseases
  • Others
  • Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review:

  • Comparison of leading molecular diagnosticanalyzers.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
  • PCR
  • bDNA
  • SDA
  • NASBA
  • TMA
  • SSSR, and others
  • LCR
  • Companies, universities and research centers developing new molecular- diagnostictechnologies and products.

Competitive Assessments:

  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Opportunities and Strategic Recommendations:

  • New product development opportunities with potentially significant market appeal during the next five years.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Read more and order at 2017 Austria Nucleic Acid Testing (NAT) Market 2021: Supplier Strategies, Country Volume and Sales Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

2017 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Country Segment Forecasts, Emerging Technologies, Competitive Strategies – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2017 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Country Segment Forecasts, Emerging Technologies, Competitive Strategies Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new study 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

– Market shares of leading suppliers
– Business and technological trends in major markets
– Five-year test volume and sales forecasts
– Market shares of leading competitors
– Feature comparison of major analyzers
– Strategic profiles of leading market players and start-up firms developing innovative products
– Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Spain Market Overview

– Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.

– Five-year test volume and sales projections.

Market Segmentation Analysis

– Five-year test volume and sales projections:

– Infectious Diseases- Forensic Testing
-Cancer- Paternity Testing/HLA Typing
– Genetic Diseases- Others- – A comprehensive analysis of the sequencing market by laboratory segment.

– Detailed market segmentation analysis, including review of the market dynamics, trends,
structure, size, growth and major suppliers.

Product/Technology Review

– Comparison of the major molecular diagnosticanalyzers.

– Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
trends in testing automation and over target/signal amplification methods.

– Worldwide listings of companies, universities and research centers developing new molecular
diagnostictechnologies and products.

Competitive Assessments

– Extensive strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative arrangements and
new technologies/products in R&D.

– Abbott
– Affymetrix
– Agilent Technologies
– Applied Gene Technologies
– Arca Biopharma
– Beckman Coulter/Danaher
– Becton Dickinson
– Biokit
– BioMerieux
– Bio-Rad
– Biotest
– CellMark Forensics/LabCorp
– Cepheid
– Decode Genetics
– Diadexus
– Eiken
– Elitech Group
– Enzo
– Exact Sciences
– Fujirebio
– Grifols
– Hologic/Gen-Probe
– Illumina
– Kreatech/Leica
– Li-Cor Biosciences
– Monogram Biosciences
– Myriad Genetics
– Ortho-Clinical Diagnostics
– Perkin Elmer/Caliper
– Proteome Sciences
– Qiagen
– Roche
– Scienion
– Sequenom
– Shimadzu
– Siemens
– Sierra Molecular
– Takara Bio
– Tecan Group
– Thermo Fisher

– Comprehensive listings of companies developing and marketing molecular
diagnostic products, by test and application.

Opportunities and Strategic Recommendations

– Specific new product development opportunities with potentially significant market appeal
during the next five years.

– Design criteria for new products.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 407 pages

Read more and order at 2017 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Country Segment Forecasts, Emerging Technologies, Competitive Strategies

Saudi Arabia Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Saudi Arabia Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights

– Five-year test volume and sales forecasts
– Feature comparison of major analyzers
– Profiles of market players and start-up firms developing innovative technologies
and products
– Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis

– Five-year test volume and sales forecasts for major applications, including:

&nbsp&nbsp- Infectious Diseases &nbsp&nbsp- Forensic Testing
&nbsp&nbsp- Cancer&nbsp &nbsp &nbsp- Paternity Testing/HLA Typing
&nbsp&nbsp- Genetic Diseases &nbsp&nbsp- Others

– Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review

– Comparison of leading molecular diagnosticanalyzers.

– Review of molecular diagnostic technologies, test formats, detection methodologies,
trends in testing automation and over 30 target/signal amplification methods, including:

– PCR – bDNA
– SDA – NASBA
– TMA – SSSR, and others
– LCR

– Companies, universities and research centers developing new molecular-
diagnostictechnologies and products.

Competitive Assessments

– Strategic profiles of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative arrangements and
new technologies/products in R&D.

Opportunities and Strategic Recommendations

– New product development opportunities with potentially significant market appeal
during the next five years.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Read more and order at Saudi Arabia Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Continuous Assessment of the Molecular Diagnostic Market for Enterovirus Tests in Switzerland, 2016 – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Continuous Assessment of the Molecular Diagnostic Market for Enterovirus Tests in Switzerland, 2016 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

Continuous Assessment of molecular diagnostics from the end user perspective. Hospital and private laboratories have systematically been surveyed to collect information on number of labs testing, NA tests, test volumes, used platforms (separated for amplification, hybridization, detection) and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:

Step 1: Identification of the total number of labs

Step 2: Identification of the total number of laboratories using NA technologies (in several lab units per hospital)

Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 39 NA tests has been provided to the labs for structured data entry. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), Traditional and Next Generation Sequencing, TMA, LCR, NASBA, SDA, HCA, bDNA.

Read more and order at Continuous Assessment of the Molecular Diagnostic Market for Enterovirus Tests in Switzerland, 2016

World Molecular Diagnostics Market 2017: Emerging Technologies and Strategic Profiles of Leading Suppliers – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The World Molecular Diagnostics Market 2017: Emerging Technologies and Strategic Profiles of Leading Suppliers Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

The report also presents strategic assessments of current and emerging suppliers of molecular diagnosticsproducts, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 180 pages

Read more and order at World Molecular Diagnostics Market 2017: Emerging Technologies and Strategic Profiles of Leading Suppliers

Switzerland Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Switzerland Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights

– Five-year test volume and sales forecasts

– Feature comparison of major analyzers

– Profiles of market players and start-up firms developing innovative technologies

and products

– Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis

– Five-year test volume and sales forecasts for major applications, including:

– Infectious Diseases – Forensic Testing

– Cancer – Paternity Testing/HLA Typing

– Genetic Diseases – Others

– Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review

– Comparison of leading molecular diagnosticanalyzers.

– Review of molecular diagnostic technologies, test formats, detection methodologies,

trends in testing automation and over 30 target/signal amplification methods, including:

– PCR – bDNA

– SDA – NASBA

– TMA – SSSR, and others

– LCR

– Companies, universities and research centers developing new molecular-

diagnostictechnologies and products.

Competitive Assessments

– Strategic profiles of major suppliers and emerging market entrants,

including their sales, product portfolios, marketing tactics, collaborative arrangements and

new technologies/products in R&D.

Opportunities and Strategic Recommendations

– New product development opportunities with potentially significant market appeal

during the next five years.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Read more and order at Switzerland Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

India Diagnostics Market 2021: Sales Forecasts for 400 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The India Diagnostics Market 2021: Sales Forecasts for 400 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report provides granular analysis of the India diagnostic testing market, including volume and sales forecasts by test for the following market segments:

  • Blood Banking
  • Cancer
  • Chemistry
  • Coagulation
  • Drugs of Abuse
  • Endocrine
  • Hematology and Flow Cytometry
  • Immunoprotein
  • Infectious Diseases
  • Molecular Diagnostics
  • TDM

Table of Contents

Market Overview

Blood Banking Market

Table 1: Blood Bank Test Volume and Reagent Sales Forecast by Test Category

Table 2: Blood Typing and Grouping Volume Forecast by Test

Table 3: Infectious Disease Screening Volume Forecast by Test

Table 4: Blood Typing and Grouping Reagent Market Forecast by Test

Table 5: Infectious Disease Screening Reagent Market Forecast by Test

Cancer Diagnostics Market

Table 6: Cancer Diagnostic Volume Forecast by Test

Table 7: Cancer Diagnostics Sales Forecast by Test

Clinical Chemistry and Immunodiagnostics Market

Table 8: Routine Chemistry Volume Forecast by Test

Table 9: Endocrine Function Volume Forecast by Test

Table 10: Tumor Markers and Special Chemistry Volume Forecast by Test

Table 11: Tumor Markers and Special Chemistry Volume Forecast by Test

Table 12: Immunoprotein Volume Forecast by Test

Table 13: TDM Volume Forecast by Test

Table 14: Drugs of Abuse Volume Forecast by Test

Table 15: Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast by Test Category

Table 16: Routine Chemistry Reagent Market Forecast by Test

Table 17: Endocrine Function Reagent Market Forecast by Test

Table 18: Tumor Markers and Special Chemistry Reagent Market Forecast by Test

Table 19: Immunoprotein Reagent Market Forecast by Test

Table 20: TDM Reagent Market Forecast by Test

Table 21: Drugs of Abuse Reagent Market Forecast by Test

Table 22: Clinical Chemistry and Immunoassay Instrument Market Forecast by Analyzer Type

Coagulation Testing Market

Table 23: Coagulation Test Volume Forecast by Procedure

Table 24: Coagulation Diagnostics Market Forecast by Product Category

Hematology and Flow Cytometry Markets

Table 25: Hematology and Flow Cytometry Specimen Volume Forecast

Table 26: Hematology and Flow Cytometry Volume Forecast

Table 27: Hematology and Flow Cytometry Market Forecast

Table 28: Routine Hematology Volume Forecast by Test

Table 29: Flow Cytometry and Special Hematology Volume Forecast by Test

Infectious Disease Testing Market

Table 30: Infectious Disease Volume Forecast by Test

Table 31: Infectious Disease Diagnostics Market Forecast by Test

Molecular Diagnostics Market

Table 32: Molecular Diagnostic Test Volume and Sales Forecasts by Application

Table 33: Molecular Diagnostic Test Volume Forecast by Application

Table 34: Infectious Disease Volume Forecast by Test

Table 35: Molecular Diagnostics Market Forecast by Application

Table 36: Infectious Disease Diagnostics Market Forecast by Test

Contains 40 pages and 36 tables.

Read more and order at India Diagnostics Market 2021: Sales Forecasts for 400 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics

Molecular Diagnostics Equipment and Reagents Market in Brazil – 2016 – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Molecular Diagnostics Equipment and Reagents Market in Brazil – 2016 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This report provides an insight into the Molecular Diagnostics Equipment and Reagents current market scenario, structure and practices in Brazil.

In depth market scenario includes;
– Market estimate of Molecular Diagnostics Equipment and Reagents in Brazil for FY16
– Geographical presence of key players in Brazil
– Providing insights into Industry drivers and challenges and their impact on the future market
– Future Market projections for 5 years
– Opportunities in the Industry

Market data and analytics are derived from a combination of primary and secondary sources

Read more and order at Molecular Diagnostics Equipment and Reagents Market in Brazil – 2016

Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department. 2017 to 2022 – Europe Version – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department. 2017 to 2022 – Europe Version Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • changing demographics
  • emerging economies and global prosperity
  • biotechnology advances in genetics
  • pathogen evolution
  • climate change
  • globalization
  • automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

"Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department. 2017 to 2022 -  Europe Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2017 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. 

Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.

The report includes detailed breakouts for 6 Countries and 1 Region. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Read more and order at Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department. 2017 to 2022 – Europe Version